litlas
Log inCreate account

Mark C. Gebhardt

Active 1981–2024

89
Papers
23,689
Citations
79
h-index
88
i10-index

Citations

Citations per year for Mark C. Gebhardt1983: 4 citations1984: 1 citations1985: 3 citations1986: 2 citations1987: 5 citations1989: 4 citations1990: 9 citations1991: 40 citations1992: 78 citations1993: 89 citations1994: 77 citations1995: 72 citations1996: 71 citations1997: 54 citations1998: 55 citations1999: 82 citations2000: 82 citations2001: 95 citations2002: 85 citations2003: 91 citations2004: 97 citations2005: 162 citations2006: 151 citations2007: 118 citations2008: 153 citations2009: 170 citations2010: 156 citations2011: 122 citations2012: 126 citations2013: 111 citations2014: 121 citations2015: 111 citations2016: 107 citations2017: 127 citations2018: 84 citations2019: 414 citations2020: 477 citations2021: 391 citations2022: 234 citations2023: 147 citations2024: 291 citations2025: 124 citations2026: 1 citations1988: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,656 citing papers, 33% of this breakdownChina: 523 citing papers, 10.4% of this breakdownItaly: 337 citing papers, 6.7% of this breakdownUnited Kingdom: 298 citing papers, 5.9% of this breakdownGermany: 250 citing papers, 5% of this breakdownFrance: 226 citing papers, 4.5% of this breakdownCanada: 195 citing papers, 3.9% of this breakdownNetherlands: 170 citing papers, 3.4% of this breakdownJapan: 137 citing papers, 2.7% of this breakdownSwitzerland: 99 citing papers, 2% of this breakdownAustralia: 86 citing papers, 1.7% of this breakdownSpain: 85 citing papers, 1.7% of this breakdown
0%33%Other 19.1%

Institutions

Fields

  • Medicine76.9%
  • Biochemistry, Genetics and Molecular Biology15.5%
  • Engineering3.2%
  • Immunology and Microbiology2.2%
  • Materials Science0.3%
  • Neuroscience0.3%
  • Other1.6%

Topics

  • Sarcoma Diagnosis and Treatment16.3%
  • Bone Tumor Diagnosis and Treatments8.2%
  • Management of metastatic bone disease4%
  • Cancer-related Molecular Pathways2.8%
  • Orthopaedic implants and arthroplasty1.7%
  • Cancer Research and Treatments1.7%
  • Other65.3%

Coauthors

All papers

Open in search
  1. Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

    Authors: Sigbjørn Smeland, Stefan Bielack, Jeremy Whelan, Mark L. Bernstein, Pancras C.W. Hogendoorn, Mark Krailo, Richard Görlick, Katherine A. Janeway, Fiona C. Ingleby, Jakob Anninga, Imre Antal, Carola Arndt, Ken Brown, Trude Butterfaß‐Bahloul, Gabriele Calaminus, Michael Capra, Catharina Dhooge, Mikael Eriksson, Adrienne M. Flanagan, Godehard Friedel, Mark C. Gebhardt, Hans Gelderblom, Robert E. Goldsby, Holcombe E. Grier, R. J. Grimer, Douglas S. Hawkins, Stefanie Hecker‐Nolting, Kirsten Sundby Hall, Michael S. Isakoff, Gordana Jovic, Thomas Kühne, Leo Kager, Thekla von Kalle, Edita Kabíčková, Susanna Lang, Ching C. Lau, Patrick J. Leavey, Stephen L. Lessnick, Leo Mascarenhas, Regine Mayer‐Steinacker, Paul A. Meyers, Raj Nagarajan, R. Lor Randall, Peter Reichardt, Marleen Renard, Catherine Rechnitzer, Cindy L. Schwartz, Sandra J. Strauss, Lisa A. Teot, Beate Timmermann, Matthew R. Sydes, Neyssa Marina - European Journal of Cancer 2019 cited by 726

  2. Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial

    Authors: Neyssa Marina, Sigbjørn Smeland, Stefan Bielack, Mark L. Bernstein, Gordana Jovic, Mark Krailo, Jane Hook, Carola Arndt, Henk van den Berg, Bernadette Brennan, Bénédicte Brichard, Ken Brown, Trude Butterfaß‐Bahloul, Gabriele Calaminus, Heike E. Daldrup‐Link, Mikael Eriksson, Mark C. Gebhardt, Hans Gelderblom, Joachim Gerß, Robert E. Goldsby, Allen M. Goorin, Richard Görlick, Holcombe E. Grier, Juliet Hale, Kirsten Sundby Hall, Jendrik Hardes, Douglas S. Hawkins, K. Helmke, Pancras C.W. Hogendoorn, Michael S. Isakoff, Katherine A. Janeway, Heribert Jürgens, Leo Kager, Thomas Kühne, Ching C. Lau, Patrick J. Leavey, Stephen L. Lessnick, Leo Mascarenhas, Paul A. Meyers, Hubert Mottl, Michaela Nathrath, Zsuzsanna Pápai, R. Lor Randall, Peter Reichardt, Marleen Renard, Akmal Safwat, Cindy L. Schwartz, Michaël C.G. Stevens, Sandra J. Strauss, Lisa A. Teot, Mathias Werner, Matthew R. Sydes, Jeremy Whelan - The Lancet Oncology 2016 cited by 541

  3. Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial

    Authors: Stefan Bielack, Sigbjørn Smeland, Jeremy Whelan, Neyssa Marina, Gordana Jovic, Jane Hook, Mark Krailo, Mark C. Gebhardt, Zsuzsanna Pápai, James S. Meyer, Helen Nadel, R. Lor Randall, Claudia Deffenbaugh, Rajaram Nagarajan, Bernadette Brennan, G. Douglas Letson, Lisa A. Teot, Allen M. Goorin, Daniel Baumhoer, Leo Kager, Mathias Werner, Ching C. Lau, Kirsten Sundby Hall, Hans Gelderblom, Paul A. Meyers, Richard Görlick, Rein hard Windhager, K. Helmke, Mikael Eriksson, Peter M. Hoogerbrugge, Paula J. Schomberg, Per‐Ulf Tunn, Thomas Kühne, Heribert Jürgens, Henk van den Berg, Tom Böhling, Susan Picton, Marleen Renard, Peter Reichardt, Joachim Gerß, Trude Butterfaß‐Bahloul, Carol D. Morris, Pancras C.W. Hogendoorn, Beatrice Seddon, Gabriele Calaminus, Maria Michelagnoli, Catharina Dhooge, Matthew R. Sydes, Mark L. Bernstein - Journal of Clinical Oncology 2015 cited by 421

  4. A System for the Functional Evaluation of Reconstructive Procedures After Surgical Treatment of Tumors of the Musculoskeletal System

    Authors: WILLIAM F. ENNEKING, WILLIAM DUNHAM, Mark C. Gebhardt, Martin Malawar, Douglas Pritchard - Clinical Orthopaedics and Related Research 1993 cited by 2,210

  5. Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group

    Authors: Paul A. Meyers, Cindy L. Schwartz, Mark Krailo, John H. Healey, Mark L. Bernstein, Donna L. Betcher, William S. Ferguson, Mark C. Gebhardt, Allen M. Goorin, Michael B. Harris, Eugenie S. Kleinerman, Michael P. Link, Helen Nadel, Michael L. Nieder, Gene P. Siegal, Michael A. Weiner, Robert J. Wells, Richard B. Womer, Holcombe E. Grier - Journal of Clinical Oncology 2008 cited by 748

  6. Addition of Ifosfamide and Etoposide to Standard Chemotherapy for Ewing's Sarcoma and Primitive Neuroectodermal Tumor of Bone

    Authors: Holcombe E. Grier, Mark Krailo, Nancy J. Tarbell, Michael P. Link, Christopher Fryer, Douglas J. Pritchard, Mark C. Gebhardt, Paul S. Dickman, Elizabeth J. Perlman, Paul A. Meyers, Sarah S. Donaldson, Sheila Moore, Aaron R. Rausen, Teresa J. Vietti, James S Miser - New England Journal of Medicine 2003 cited by 1,334

  7. Osteosarcoma: A Randomized, Prospective Trial of the Addition of Ifosfamide and/or Muramyl Tripeptide to Cisplatin, Doxorubicin, and High-Dose Methotrexate

    Authors: Paul A. Meyers, Cindy L. Schwartz, Mark Krailo, Eugenie S. Kleinerman, Donna L. Betcher, Mark L. Bernstein, Ernest U. Conrad, William S. Ferguson, Mark C. Gebhardt, Allen M. Goorin, Michael B. Harris, John H. Healey, Andrew G. Huvos, Michael P. Link, Joseph F. Montebello, Helen Nadel, Michael L. Nieder, Judith K. Sato, Gene P. Siegal, Michael A. Weiner, Robert J. Wells, Lester E. Wold, Richard B. Womer, Holcombe E. Grier - Journal of Clinical Oncology 2005 cited by 719

  8. Presurgical Chemotherapy Compared With Immediate Surgery and Adjuvant Chemotherapy for Nonmetastatic Osteosarcoma: Pediatric Oncology Group Study POG-8651

    Authors: Allen M. Goorin, Douglas J. Schwartzentruber, Meenakshi Devidas, Mark C. Gebhardt, Alberto G. Ayala, Michael B. Harris, Lee J. Helman, Holcombe E. Grier, Michael P. Link - Journal of Clinical Oncology 2003 cited by 395

  9. MicroRNA paraffin-based studies in osteosarcoma reveal reproducible independent prognostic profiles at 14q32

    Authors: Andrew D. Kelly, Benjamin Haibe‐Kains, Katherine A. Janeway, Katherine E. Hill, Eleanor Howe, Jeffrey D. Goldsmith, Kyle C. Kurek, Antonio R. Pérez‐Atayde, Nancy Francoeur, Jian‐Bing Fan, Craig April, Hal E. Schneider, Mark C. Gebhardt, Aedín C. Culhane, John Quackenbush, Dimitrios Spentzos - Genome Medicine 2013 cited by 118

  10. Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group

    Authors: Cindy L. Schwartz, Leonard H. Wexler, Mark Krailo, Lisa A. Teot, Meenakshi Devidas, Laurel J. Steinherz, Allen M. Goorin, Mark C. Gebhardt, John H. Healey, Judith K. Sato, Paul A. Meyers, Holcombe E. Grier, Mark L. Bernstein, Steven E. Lipshultz - Pediatric Blood & Cancer 2015 cited by 92

  11. USP6 and CDH11 Oncogenes Identify the Neoplastic Cell in Primary Aneurysmal Bone Cysts and Are Absent in So-Called Secondary Aneurysmal Bone Cysts

    Authors: André M. Oliveira, Antonio R. Pérez‐Atayde, Carrie Y. Inwards, Fabíola Medeiros, Victoria Derr, Bae‐Li Hsi, Mark C. Gebhardt, Andrew E. Rosenberg, Jonathan A. Fletcher - American Journal Of Pathology 2004 cited by 432

  12. Dose-Intensified Compared With Standard Chemotherapy for Nonmetastatic Ewing Sarcoma Family of Tumors: A Children's Oncology Group Study

    Authors: Linda Granowetter, Richard B. Womer, Meenakshi Devidas, Mark Krailo, Chenguang Wang, Mark L. Bernstein, Neyssa Marina, Patrick J. Leavey, Mark C. Gebhardt, John H. Healey, Robert C. Shamberger, Allen M. Goorin, James S Miser, James S. Meyer, Carola A.S. Arndt, Scott L. Sailer, Karen J. Marcus, Elizabeth J. Perlman, Paul S. Dickman, Holcombe E. Grier - Journal of Clinical Oncology 2009 cited by 332

  13. Clinical and Biochemical Manifestations of Hyaluronidase Deficiency

    Authors: Marvin R. Natowicz, M. Priscilla Short, Yu Wang, G. Richard Dickersin, Mark C. Gebhardt, Daniel I. Rosenthal, Katherine B. Sims, Andrew E. Rosenberg - New England Journal of Medicine 1996 cited by 205

  14. Long-Term Results of Allograft Replacement in the Management of Bone Tumors

    Authors: Henry J. Mankin, Mark C. Gebhardt, L. Candace Jennings, Dempsey S. Springfield, William W. Tomford - Clinical Orthopaedics and Related Research 1996 cited by 671

  15. Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi‐modality therapy: A report from the Children's Oncology Group

    Authors: Patrick J. Leavey, Leo Mascarenhas, Neyssa Marina, Zhengjia Chen, Mark Krailo, James S Miser, Ken Brown, Nancy J. Tarbell, Mark L. Bernstein, Linda Granowetter, Mark C. Gebhardt, Holcombe E. Grier - Pediatric Blood & Cancer 2008 cited by 204

  16. Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: A report from the Children's Oncology Group

    Authors: Steven G. DuBois, Mark Krailo, Mark C. Gebhardt, Sarah S. Donaldson, Karen J. Marcus, John P. Dormans, Robert C. Shamberger, Scott L. Sailer, Richard W. Nicholas, John H. Healey, Nancy J. Tarbell, R. Lor Randall, Meenakshi Devidas, James S. Meyer, Linda Granowetter, Richard B. Womer, Mark L. Bernstein, Neyssa Marina, Holcombe E. Grier - Cancer 2014 cited by 188

  17. Phase II/III Trial of Etoposide and High-Dose Ifosfamide in Newly Diagnosed Metastatic Osteosarcoma: A Pediatric Oncology Group Trial

    Authors: Allen M. Goorin, Michael B. Harris, Mark L. Bernstein, William S. Ferguson, Meenakshi Devidas, Gene P. Siegal, Mark C. Gebhardt, Cindy L. Schwartz, Michael P. Link, Holcombe E. Grier - Journal of Clinical Oncology 2002 cited by 145

  18. Editorial

    Authors: Seth S. Leopold, Lee Beadling, Matthew B. Dobbs, Mark C. Gebhardt, Paul A. Lotke, Paul Manner, Clare M. Rimnac, Montri D. Wongworawat - Clinical Orthopaedics and Related Research 2013 cited by 99

  19. p53 functions as a cell cycle control protein in osteosarcomas.

    Authors: Lisa Diller, J Kassel, C. Nelson, Magdalena A. Gryka, Gregory Litwak, Mark C. Gebhardt, B Bressac, Mehmet Öztürk, Suzanne J. Baker, Bert Vogelstein - Molecular and Cellular Biology 1990 cited by 767

  20. Aneurysmal Bone Cyst: A Review of 150 Patients

    Authors: Henry J. Mankin, Francis J. Hornicek, Eduardo J. Ortiz‐Cruz, Jorge Villafuerte, Mark C. Gebhardt - Journal of Clinical Oncology 2005 cited by 460

  21. Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas

    Authors: Thomas F. DeLaney, Ira J. Spiro, Herman D. Suit, Mark C. Gebhardt, Francis J. Hornicek, Henry J. Mankin, Andrew Rosenberg, Daniel I. Rosenthal, Fariba Miryousefi, Marcus Ancukiewicz, David C. Harmon - International Journal of Radiation Oncology*Biology*Physics 2003 cited by 307

  22. Aneurysmal bone cyst variant translocations upregulate USP6 transcription by promoter swapping with the ZNF9, COL1A1, TRAP150, and OMD genes

    Authors: André M. Oliveira, Antonio R. Pérez‐Atayde, Paola Dal Cin, Mark C. Gebhardt, Chang-Jie Chen, James R. Neff, George D. Demetri, Andrew E. Rosenberg, Julia A. Bridge, Jonathan A. Fletcher - Oncogene 2005 cited by 248

  23. p53 Functions as a Cell Cycle Control Protein in Osteosarcomas

    Authors: Lisa Diller, J Kassel, Camille E. Nelson, Magdalena A. Gryka, Gregory Litwak, Mark C. Gebhardt, Brigitte Bressac–de Paillerets, Mehmet Öztürk, Suzanne J. Baker, Bert Vogelstein, Stephen Friend - Molecular and Cellular Biology 1990 cited by 228

  24. Vinblastine and Methotrexate for Desmoid Fibromatosis in Children: Results of a Pediatric Oncology Group Phase II Trial

    Authors: Stephen X. Skapek, William S. Ferguson, Linda Granowetter, Meenakshi Devidas, Antonio R. Pérez‐Atayde, Louis P. Dehner, Fredric A. Hoffer, Roseanne Speights, Mark C. Gebhardt, Gary V. Dahl, Holcombe E. Grier - Journal of Clinical Oncology 2007 cited by 195